
NVST Earnings Date: Nov 4, 2026 (Estimated) — Envista Holdings Corp
NYSE · Healthcare · Medical Instruments & Supplies
Updated
When is NVST's next earnings date?
Envista Holdings Corp (NVST) is expected to report Q3 2026 earnings on Wednesday, November 4, 2026 at 4:00 PM ET (after market close); the date is an estimate and has not been confirmed by the company. The consensus estimate is EPS of $0.36 on revenue of $688.7M.
How did NVST do in its last earnings report?
In its most recent report on Aug 5, 2026 (Q2 2026), Envista Holdings Corp posted EPS of $0.41 versus the $0.34 estimate, a beat of 24.2%. Revenue was $730.5M against a $716.1M estimate. The stock's 1-day post-earnings move was -4.4%.
How much does NVST stock move after earnings?
NVST beat EPS estimates in 5 of its last 8 reported quarters. Over the last 8 reports the stock moved an average of 7.4% (up or down) in the day after earnings.
About Envista Holdings Corp
Envista Holdings Corporation is an enterprise dedicated to the development and distribution of a comprehensive range of dental solutions. These offerings are crucial for the identification, therapeutic intervention, and preventative care of diverse oral health issues, specifically addressing the teeth, gingiva (gums), and their supporting bone structures. The company's principal location is in Brea, California, and it maintains a workforce comprising 12,800 full-time personnel. The firm organizes its business activities into two main divisions: "Specialty Products & Technologies" and "Equipment & Consumables." The Specialty Products & Technologies division concentrates on the creation, fabrication, and promotion of sophisticated dental implant systems, advanced prosthetic devices, and their associated digital treatment software and technological advancements. This segment also provides orthodontic remedies, including bracket systems, clear aligners, and various items for dental laboratories. Conversely, the Equipment & Consumables division is responsible for conceptualizing, producing, and bringing to market a wide array of dental apparatus and vital supplies intended for professional dental clinics. This extensive catalog includes digital imaging instruments, specialized software, and visual or magnification systems; patient treatment units and other essential fixtures for dental practices; complete endodontic kits along with their complementary consumable items; materials and tools for restorative dentistry; rotary cutting tools (burs); impression-making compounds; adhesive agents and dental cements; and products designed for infection control.
Earnings History
| Date | Period | EPS Est. | EPS Act. | Surprise | Revenue | Result | 1D Δ | 1W Δ | 1M Δ |
|---|---|---|---|---|---|---|---|---|---|
| 2026-08-05 | Q2 2026 | 0.34 | 0.41 | +24.24% | $730.5M | ✅ Beat | -4.37% | +0.28% | -3.63% |
| 2026-05-06 | Q1 2026 | 0.31 | 0.36 | +16.13% | $705.5M | ✅ Beat | -10.27% | -11.64% | -14.67% |
| 2026-02-05 | Q4 2025 | 0.32 | 0.38 | +18.75% | $750.6M | ✅ Beat | +17.77% | +16.43% | +8.05% |
| 2025-10-29 | Q3 2025 | 0.27 | 0.32 | +18.52% | $669.9M | ✅ Beat | +0.80% | +0.85% | +4.60% |
| 2025-07-31 | Q2 2025 | 0.23 | 0.26 | +13.04% | $682.0M | ✅ Beat | +10.27% | +6.35% | +12.12% |
| 2024-08-07 | Q2 2024 | 0.28 | 0.11 | -60.71% | $633.1M | ❌ Miss | +7.84% | +13.14% | +13.99% |
| 2024-05-01 | Q1 2024 | 0.32 | 0.26 | -18.75% | $623.6M | ❌ Miss | +0.30% | -4.66% | -1.97% |
| 2024-02-07 | Q4 2023 | 0.34 | 0.29 | -14.71% | $645.6M | ❌ Miss | -7.43% | -8.66% | -12.42% |
Showing last 8 quarters.
Revenue by segment & region
By segment
Q4 FY24 · $1.89B total
| Segment | Share | Revenue | YoY | Q4 FY22 | Q1 FY23 | Q2 FY23 | Q3 FY23 |
|---|---|---|---|---|---|---|---|
| Specialty Products and Technologies | 64.0% | $1.21B | +46.2% | — | — | $417.0M | $399.5M |
| Equipment and Consumables | 36.0% | $679.3M | +52.0% | — | — | $245.4M | $231.8M |
By region
Q2 FY26 · $530.0M total
| Segment | Share | Revenue | YoY | Q3 FY25 | Q1 FY26 | Q2 FY26 |
|---|---|---|---|---|---|---|
| North America | 68.8% | $364.7M | +4.8% | $348.1M | $364.2M | $364.7M |
| Western Europe | 31.2% | $165.3M | +7.3% | $139.1M | $184.8M | $165.3M |
Source: company filings via FMP. YoY compares the same fiscal period a year earlier.